The biggest angel investing network in Wisconsin said Wednesday it has invested $535,000 in eMetagen Corp., a drug-development company in Madison. The firm’s business is based on proprietary technology for finding and developing drugs that was discovered at UW-Madison.
Office of Strategic Communication